US 11253509
Methods of treatment for cystic fibrosis
granted A61KA61K31/4045A61K31/443
Quick answer
US patent 11253509 (Methods of treatment for cystic fibrosis) held by Vertex Pharmaceuticals Incorporated expires Mon Feb 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Feb 22 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K31/4045, A61K31/443, A61K31/4439, A61K31/454